September 26, 2023 — Exo (pronounced “echo”), a medical imaging software and device company, today unveiled a category-redefining handheld ultrasound device,
September 26, 2023 — Artificial intelligence(AI) and machine learning tools have received a lot of attention recently, with the majority of discussions focusing on proper use. However, this technology has a wide range of practical applications, from predicting natural disasters to addressing racial inequalities and now, assisting in cancer surgery.
September 25, 2023 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, today announced new clinical data supporting advancements in pulmonary embolism (PE) detection. Two studies have demonstrated the real-world clinical efficacy of Viz.ai's PE Module to quickly and accurately identify PE and associated right heart strain, accelerate care coordination, and improve healthcare workflow efficiency.
Since the advent of the magnetic resonance imaging (MRI) exam on human patients in the late 1970s, this innovation offered a multi-layered and noninvasive approach to the imaging of bodily organs, functions and the ability to diagnose disease. The MRI design applies the use of a radio frequency and a large magnet to generate visual reports of structures inside the body to monitor a major set of conditions.¹
If you enjoy this content, please share it with a colleague
Earlier this year, I had the opportunity to sit down and talk with leading breast cancer specialist Wendie Berg, MD, PhD, professor of radiology at the University of Pittsburgh School of Medicine, and Magee Women’s Hospital of UPMC specializing in breast imaging. I asked Dr. Berg what still needs to be done in the fight against breast cancer and in reinforcing the importance of early detection.
September 22, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced a pioneering study result, recently published in
In countries with organized screening programs, regular breast cancer screening has been a crucial tool in the clinician toolkit, decreasing breast cancer mortality rates by up to 40%.
If you enjoy this content, please share it with a colleague